Targeting LRP6: A new strategy for cancer therapy

Targeting specific molecular drivers of tumor growth is a key approach in cancer therapy. Among these targets, the low-density lipoprotein receptor-related protein 6 (LRP6), a vital component of the Wnt signaling pathway, has emerged as an intriguing candidate. As a cell-surface receptor and vital c...

Full description

Bibliographic Details
Main Authors: Wei Xue, Bo Zhu, Kaili Zhao, Qiuju Huang, Hua Luo, Yiwen Shou, Zhaoquan Huang, Hongwei Guo
Format: Article
Language:English
Published: Elsevier 2024-06-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1043661824001440